Top Markets
Coin of the day
BioPorto A/S BioPorto A/S

BioPorto A/S

BIOPOR
Rank in Stocks #21789
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
Share Price
$0.20243542
Last synced: 2026-08-21
Market Cap
$100.22M
Change (1 day)
2.00%
Change (1 year)
-0.82%
Country
DK
Trade BioPorto A/S (BIOPOR)

Category

P/S ratio for BioPorto A/S (BIOPOR)
P/S ratio as of 2026 TTM: 0
According to BioPorto A/S latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for BioPorto A/S from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
4.72 -
US
5.67 -
US
- -
CN
16.40 -
US
5.80 -
US